Position in AVTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$38,356,071
+$13,977,696 QoQ
Shares Held
2,075,545
+27.1% QoQ
Ownership
3.87%
of shares outstanding
% of Portfolio
1.07%
of 13F equity value
Holder Rank
#12
of 126 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in AVTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BVF INC/IL holds $3,440,293,274 across 41 Biotechnology names. AVTX ranks #23 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,965,160 | $555,315,164 | |
| 2 | KYMR |
Kymera Therapeutics, Inc.
|
3,872,052 | $444,008,202 | |
| 3 | MLTX |
MoonLake Immunotherapeutics
|
16,001,284 | $311,544,999 | |
| 4 | GHRS |
GH Research PLC
|
8,650,158 | $232,516,247 | |
| 5 | GPCR |
Structure Therapeutics Inc.
|
3,366,823 | $180,697,390 | |
| 6 | NKTR |
Nektar Therapeutics
|
2,391,075 | $166,920,945 | |
| 7 | MIRM |
Mirum Pharmaceuticals, Inc.
|
1,056,027 | $123,629,080 | |
| 8 | XNCR |
Xencor Inc
|
7,133,720 | $114,852,892 |
All Filings in AVTX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $38,356,071 | 2,075,545 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $24,378,375 | 1,632,845 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $24,611,467 | 1,355,257 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $17,225,303 | 1,355,256 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $5,129,964 | 1,028,049 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $8,303,798 | 1,036,679 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $7,702,524 | 1,036,679 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $9,186,500 | 967,000 | Shares | Defined | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||